Back to the main directory
EarningsReview / Equity
- Europris (Buy, TP: NOK80.00) - Closing in on Swedish expansion by DnB Markets
- Dometic (Buy, TP: SEK105.00) - Resilience in a small quarter by DnB Markets
- Rate cutting cycle should drive a re-rating by BNP Paribas Exane
- 2024 gold outlook - expert event feedback by BNP Paribas Exane
- Saucony IP Sale Announced by BNP Paribas Exane
- One Step Ahead, or Behind? by BNP Paribas Exane
- Abionyx Pharma - Nouveau lot pour la molécule CER-001 by MidCap Partners
- INVEST SECURITIES – DIASORIN : Rendez-vous gâché par des objectifs décevants - NEUTRE, OC 92€ by Invest Securities
- Games Workshop Group - Licensed content agreement with Amazon by Edison Investment Research
- Abionyx Pharma - New batch for the CER-001 molecule by MidCap Partners
- Entive Smart Kitchen Appliance (300911 CH) by HSBC
- Filtronic - Further momentum with £4.5m defence contract by Edison Investment Research
- Non material data changes by BNP Paribas Exane
- Solid trends continue by BNP Paribas Exane
- Hexpol (Hold, TP: SEK130.00) - Closing in on its fair value by DnB Markets
- Investors’ deepwater expectations better aligned with reality by DnB Markets
- A return to former glories by BNP Paribas Exane
- Q2 EBIT -4% vs. cons; revenue guidance cut again by BNP Paribas Exane
- Significant room for improvement by BNP Paribas Exane
- Three stages of evolution; caution, consolidation, creation by BNP Paribas Exane
- INVEST SECURITIES – TME PHARMA : Survie médiane finale attendue entre 19 et 19,9 mois - ACHAT, OC 0,4€ by Invest Securities
- Filtronic - $6.0m win further strengthens space credentials by Edison Investment Research
- Pan American Silver - Skarn PEA confirms its early potential by Edison Investment Research
- MedinCell - 1st royalties received in H1, reduced losses by MidCap Partners
- F2Q24 Quick Take by BNP Paribas Exane